Copart's $1.9 Billion All-Cash Bet on ACV: A Quality Compounder Buying Growth

Copart, the company best known for running the online salvage-car auction where insurers send wrecked vehicles, announced its largest acquisition ever on September 10: a roughly $1.9 billion, all-cash purchase of ACV Auctions. The announcement landed the same afternoon Copart reported a quarter where total operating costs rose 10% against just 2.4% revenue growth — a telling pairing, because the new deal only starts paying off at the very point Copart is scrambling to contain its own cost-per-car problem.

This is a story about a fortress balance sheet buying its way back into growth, and the honesty of that trade matters more than the headline price.

A compounder that quietly stalled

Copart's economics are genuinely elite. Gross margin runs around 87%, return on invested capital is in the mid-teens, and the balance sheet carries no borrowings against roughly $4.5 billion in cash and short-term securities at fiscal year-end. That last number is the whole reason this deal exists: few large-cap buyers can write a ~$1.9 billion check without a financing clause.

But the operating engine has gone strangely quiet. For the fiscal year ended July 31, 2026, revenue grew just 0.4% to about $4.7 billion, while net income attributed to Copart fell 4.4%. The fourth quarter was the sharper version: earnings per share dropped 14.6% as total operating expenses climbed 10% to $783.5 million, a squeeze that pushed operating income down 10.6%. Investors have noticed — the stock is down more than 20% year-to-date and off roughly one-third over the past twelve months, a startling reversal for a name with historically compounder-grade momentum. The market has already repriced the multiple: Copart trades near 18x trailing earnings and about 12.6x EV/EBITDA after the slide of the past year.

The bet: buying an adjacent channel

ACV is not another salvage auctioneer. Where Copart dominates the disposition of insurer-totaled vehicles — about 5 million cars a year through a physical network of over 250 yards — ACV runs a dealer-to-dealer wholesale marketplace where dealerships trade whole, drivable used cars with each other, a channel roughly four times larger than Copart's own. Management framed the two as "adjacent rather than overlapping", and the pitch is a fully digital, end-to-end remarketing platform: an inspected car can move from dealer trade-in through wholesale auction and, if damaged, into salvage disposition.

The price is $10.50 a share in cash, a ~45% premium to ACV's unaffected price, all funded from cash on hand with no financing condition and a target close by calendar year-end. ACV is a growing but still loss-making asset by GAAP — it reported Q2 2026 revenue up 10% to $214 million with a record $21 million in adjusted EBITDA, yet a roughly $8 million net loss, inside a dealer wholesale market that contracted about 6%. You are not buying a profitable machine; you are buying scale in a market Copart does not lead, plus a proprietary condition-inspection and data layer ACV built.

The honest part: accretion is a promise, not a fact

Here is where the deal deserves a cold read. Copart says the transaction will be neutral on EPS in its first full year and only "accretive in fiscal 2028 and beyond", on the back of expected cost and revenue synergies. Translate that: in year one, buying an unprofitable company does not add to per-share earnings — a $1.9 billion cash outlay that currently pays no return. The EPS lift does not arrive until roughly two years out, and it is contingent on Copart actually finding the integration savings it claims.

That timing collides with the pressure the company is already under. If the merger is supposed to help combine cost bases, Copart first has to show it can hold its own expenses — which rose 10% in the latest quarter on near-flat unit growth. Cost per car was already creeping up before this deal added a $1.9 billion integration on top. The resilience here is real, but it is Copart's fortress balance sheet that absorbs the risk, not a proven synergy plan.

What it means for the portfolio

On a factor basis, Copart still scores as a quality-growth name — exceptional profitability, effectively no leverage, mid-teens return on capital — but the growth and momentum read is genuinely mixed right now, and the ACV deal does not fix that in the near term. It is a bet with a delayed payoff: the cash means survival risk is negligible, and if Copart integrates ACV well, it gains a growth vector in a channel four times its size and a fresh timeline to re-accelerate revenue.

The disciplined read is to treat this not as an instant upgrade but as a thesis that management must now execute. Watch two things: whether Copart's own expense-per-unit growth stops climbing, and whether the "accretive in FY 2028" path shows up in actual cost and revenue numbers before the market re-rates it. The balance sheet buys Copart the time. The question the market is really pricing — at 18x after a 36% derating — is whether management can turn that time into growth the past year failed to deliver.